What the Stark II phase III rules mean for you
In August, the Centers for Medicare & Medicaid Services released the third, and final, version of the Stark II rules.
In August, the Centers for Medicare & Medicaid Services released the third, and final, version of the Stark II rules. Under the Stark II rules, Medicare patients cannot be referred to facilities in which a physician has a financial interest-unless the financial arrangement meets one of a number of exceptions.
While the final rule does not make sweeping changes to the existing prohibitions, nor does it include any new exceptions for physicians and others, CMS has tried to make the rule more flexible. According to American Medical News (9/24/2007), the final rule:
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
